Page last updated: 2024-10-19

1-octanol and Parkinson Disease

1-octanol has been researched along with Parkinson Disease in 1 studies

1-Octanol: A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
octan-1-ol : An octanol carrying the hydroxy group at position 1.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denora, N1
Cassano, T1
Laquintana, V1
Lopalco, A1
Trapani, A1
Cimmino, CS1
Laconca, L1
Giuffrida, A1
Trapani, G1

Other Studies

1 other study available for 1-octanol and Parkinson Disease

ArticleYear
Novel codrugs with GABAergic activity for dopamine delivery in the brain.
    International journal of pharmaceutics, 2012, Nov-01, Volume: 437, Issue:1-2

    Topics: 1-Octanol; Acetamides; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette

2012